Suraksha Diagnostic Accumulates ₹254 Crore From Anchor Investors

Suraksha Diagnostic Ltd., an integrated diagnostic chain based in Kolkata, successfully raised ₹254 crores from anchor investors ahead of its IPO opening. The significant funding comes just one day before the company opens its IPO for public subscription.

The list of anchor investors includes some of the biggest names in the industry, such as Nippon Mutual Funds, Kotak MF, Aditya Birla Sun Life MF, and Carnelian Bharat Amritkaal Fund, according to a circular uploaded on the Bombay Stock Exchange (BSE) website.

In addition, the company has distributed 57.57 lakh equity shares to 16 distinct funds at a price of ₹441 apiece, which is the maximum end of the price range. Strong investor trust in the company's growth potential is demonstrated by this allocation, which comes to ₹254 crore.

With the price range between ₹420-₹441 apiece, Suraksha Diagnostic's IPO will open on November 29 and close on December 3.

During fiscal 2024, it conducted about 5.98 million tests serving approximately 1.14 million patients. Thus, with a strong track record of growth and a dominant position in the eastern Indian diagnostic market, Suraksha Diagnostic's IPO is expected to attract significant investor interest.